Hysbysiad contract
Adran I:
Endid
contractio
I.1) Enw a chyfeiriad
NHS Blood and Transplant
203 Longmead Rd, Avon
Bristol
BS16 7FG
UK
Person cyswllt: Jakob Kauusberg
Ffôn: +44 7385015072
E-bost: jakob.kauusberg@nhsbt.nhs.uk
NUTS: UKK12
Cyfeiriad(au) rhyngrwyd
Prif gyfeiriad: https://www.nhsbt.nhs.uk
Cyfeiriad proffil y prynwr: https://www.nhsbt.nhs.uk
I.3) Cyfathrebu
Mae'r dogfennau caffael ar gael ar gyfer mynediad uniongyrchol anghyfyngedig a llawn, yn rhad ac am ddim ar:
https://health-family.force.com/s/Welcome
Gellir cael gwybodaeth ychwanegol o'r cyfeiriad uchod
Rhaid anfon tendrau neu geisiadau i gymryd rhan yn electronig at:
https://health-family.force.com/s/Welcome
Rhaid anfon tendrau neu geisiadau i gymryd rhan i'r cyfeiriad uchod:
Mae cyfathrebu electronig yn gofyn am ddefnyddio offer a dyfeisiau nad ydynt ar gael yn gyffredinol. Mae mynediad uniongyrchol anghyfgyfyngiedig a llawn i'r offer a dyfeisiau hyn yn bosibl, yn rhad ac am ddim, yn:
https://health-family.force.com/s/Welcome
I.4) Y math o awdurdod contractio
Corff a lywodraethir gan gyfraith gyhoeddus
I.5) Prif weithgaredd
Iechyd
Adran II: Gwrthrych
II.1) Cwmpas y caffaeliad
II.1.1) Teitl
Supply of New Sterile Connection Devices
Cyfeirnod: C220866
II.1.2) Prif god CPV
33100000
II.1.3) Y math o gontract
Cyflenwadau
II.1.4) Disgrifiad byr
Supply of Sterile Connection Devices, Consumables, Repair and Maintenance
II.1.5) Cyfanswm gwerth amcangyfrifedig
Gwerth heb gynnwys TAW: 1 000 000.00 GBP
II.1.6) Gwybodaeth am lotiau
Mae’r contract hwn wedi’i rannu’n lotiau:
Na
II.2) Disgrifiad
II.2.2) Cod(au) CPV ychwanegol
50400000
33100000
II.2.3) Man cyflawni
Cod NUTS:
UK
Prif safle neu fan cyflawni:
NHS Blood and Transplant<br/>500 North Bristol Park<br/>Bristol<br/>BS34 7QH
II.2.4) Disgrifiad o’r caffaeliad
NHS Blood and Transplant (NHSBT) is a special health authority providing a blood and transplantation service to the NHS, looking after blood donation services in England and transplant services across the UK. This includes managing the donation, storage and transplantation of blood and blood components, organs, tissues, bone marrow and stem cells, and researching new treatments and processes.<br/><br/>As an essential part of the NHS we take pride in playing our part to make the most of absolutely every donation – from blood and organs to tissues and stem cells. With the support of our amazing donors, we give a lifeline to thousands of people every year. But there is always more to do, which is why we continually strive to improve the safety, availability, quality and efficiency of our services.<br/><br/>SCDs are essential for NHSBT to produce a wide range of blood components. They are used to connect ancillary packs to primary components to allow the manufacture of secondary components (washed red cells or platelets), in the production of pooled components (platelets, granulocytes and cryoprecipitate) and to manufacture neonatal split components (red cells, plasma and platelets). SCD’s are also used during bacterial screening and in areas outside of blood supply such as Tissue Services, Cellular and Molecular Therapy (CMT). <br/><br/>SCDs are essential for NHSBT to produce a wide range of blood components. They are used to connect ancillary packs to primary components to allow the manufacture of secondary components (washed red cells or platelets), in the production of pooled components (platelets, granulocytes and cryoprecipitate) and to manufacture neonatal split components (red cells, plasma and platelets). SCD’s are also used during bacterial screening and in areas outside of blood supply such as Tissue Services, Cellular and Molecular Therapy (CMT). <br/><br/>This framework is being conducted via our Atamis portal: https://health-family.force.com/s/Welcome
II.2.5) Meini prawf dyfarnu
Nid pris yw’r unig faen prawf dyfarnu a dim ond yn y dogfennau caffael y mae’r holl feini prawf wedi’u nodi
II.2.6) Gwerth amcangyfrifedig
Gwerth heb gynnwys TAW: 1 000 000.00 GBP
II.2.7) Hyd y contract, y cytundeb fframwaith neu’r system brynu ddynamig
Dechrau:
01/08/2024
Diwedd:
31/07/2028
Gall y contract hwn gael ei adnewyddu: Na
II.2.9) Gwybodaeth am y cyfyngiadau ar nifer yr ymgeiswyr a gaiff eu gwahodd
II.2.10) Gwybodaeth am amrywiadau
Derbynnir amrywiadau:
Na
II.2.11) Gwybodaeth am opsiynau
Opsiynau:
Na
II.2.13) Gwybodaeth am Gronfeydd yr Undeb Ewropeaidd
Mae'r broses gaffael yn gysylltiedig â phrosiect a/neu raglen a ariennir gan gronfeydd yr Undeb Ewropeaidd:
Na
Section III: Gwybodaeth gyfreithiol, economaidd, ariannol a thechnegol
III.1) Amodau ar gyfer cymryd rhan
III.1.2) Statws economaidd ac ariannol
Meini prawf dethol fel y’u nodir yn y dogfennau caffael
III.1.3) Gallu technegol a phroffesiynol
Meini prawf dethol fel y’u nodir yn y dogfennau caffael
III.2) Amodau sy’n gysylltiedig â’r contract
Section IV: Gweithdrefn
IV.1) Disgrifiad
IV.1.1) Y math o weithdrefn
Gweithdrefn agored
IV.1.3) Gwybodaeth am gytundeb fframwaith neu system brynu ddynamig
Mae'r broses gaffael yn golygu sefydlu cytundeb fframwaith gydag un gweithredwr.
IV.1.8) Gwybodaeth am Gytundeb Caffael y Llywodraeth (GPA)
The procurement is covered by the Government Procurement Agreement:
Ydy
IV.2) Gwybodaeth weinyddol
IV.2.1) Cyhoeddiad blaenorol mewn perthynas â’r weithdrefn hon
Rhif yr hysbysiad yn OJ S:
2023/S 000-027387
IV.2.2) Terfyn amser i dendrau neu geisiadau i gymryd rhan ddod i law
Dyddiad:
11/01/2024
Amser lleol: 16:00
IV.2.4) Ym mha iaith/ieithoedd y gellir cyflwyno tendrau neu geisiadau i gymryd rhan
EN
IV.2.6) Yr isafswm cyfnod gofynnol i’r sawl sy’n tendro gynnal y tendr
Rhaid i’r tendr fod yn ddilys tan:
01/08/2024
IV.2.7) Amodau ar gyfer agor tendrau
Dyddiad:
04/12/2023
Amser lleol: 16:00
Place:
https://health-family.force.com/s/Welcome
Section VI: Gwybodaeth ategol
VI.1) Gwybodaeth am ailddigwydd
Caffaeliad cylchol yw hwn:
Na
VI.4) Gweithdrefnau adolygu
VI.4.1) Corff adolygu
Commercial Court
7 Rolls Building, Fetter Lane
London
EC4A 1NL
UK
VI.5) Dyddiad anfon yr hysbysiad hwn
04/12/2023